Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5289780
Max Phase: Preclinical
Molecular Formula: C19H13N3O2
Molecular Weight: 315.33
Associated Items:
ID: ALA5289780
Max Phase: Preclinical
Molecular Formula: C19H13N3O2
Molecular Weight: 315.33
Associated Items:
Canonical SMILES: C#Cc1ccc2c3nn(-c4ccc(OC)cc4)c(=O)c-3c[nH]c2c1
Standard InChI: InChI=1S/C19H13N3O2/c1-3-12-4-9-15-17(10-12)20-11-16-18(15)21-22(19(16)23)13-5-7-14(24-2)8-6-13/h1,4-11,20H,2H3
Standard InChI Key: YYWZERFWKQOHSU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 315.33 | Molecular Weight (Monoisotopic): 315.1008 | AlogP: 2.81 | #Rotatable Bonds: 2 |
Polar Surface Area: 59.91 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.64 | CX Basic pKa: 2.41 | CX LogP: 2.41 | CX LogD: 2.41 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.58 | Np Likeness Score: -1.18 |
1. Simeone X, Iorio MT, Siebert DCB, Rehman S, Schnürch M, Mihovilovic MD, Ernst M.. (2019) Defined concatenated α6α1β3γ2 GABAA receptor constructs reveal dual action of pyrazoloquinolinone allosteric modulators., 27 (14): [PMID:31186146] [10.1016/j.bmc.2019.06.006] |
Source(1):